1-20 of 21
Roger Stupp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma

Karl J. Habashy, Crismita Dmello, Li Chen, Victor A. Arrieta, Kwang-Soo Kim, Andrew Gould, Mark W. Youngblood, Guillaume Bouchoux, Kirsten B. Burdett, Hui Zhang, Michael Canney, Roger Stupp, Adam M. Sonabend
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (8): 1619–1629.
https://doi.org/10.1158/1078-0432.CCR-23-2367
Published: 15 April 2024
View article titled, Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma
Open the PDF for Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma in another window
Includes: Supplementary data
Journal Articles

ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis

Víctor A. Arrieta, Johnny Duerinck, Kirsten B. Burdett, Karl J. Habashy, Wietse Geens, Andrew Gould, Julia K. Schwarze, Crismita Dmello, Kwang-Soo Kim, Ruth Saganty, Li Chen, Alberto Moscona, Matthew McCord, Catalina Lee-Chang, Craig M. Horbinski, Hui Zhang, Roger Stupp, Bart Neyns, Adam M. Sonabend
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (2): 379–388.
https://doi.org/10.1158/1078-0432.CCR-23-1889
Published: 17 January 2024
View article titled, ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Open the PDF for ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis in another window
Includes: Supplementary data
Journal Articles

Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma

Crismita Dmello, Aarón Sonabend, Victor A. Arrieta, Daniel Y. Zhang, Deepak Kanojia, Li Chen, Andrew Gould, Jiangshan Zhang, Seong Jae Kang, Jan Winter, Craig Horbinski, Christina Amidei, Balázs Győrffy, Alex Cordero, Catalina Lee Chang, Brandyn Castro, Patrick Hsu, Atique U. Ahmed, Maciej S. Lesniak, Roger Stupp, Adam M. Sonabend
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (14): 3156–3169.
https://doi.org/10.1158/1078-0432.CCR-21-2563
Published: 15 July 2022
View article titled, Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma
Open the PDF for Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

Stephen J. Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Louis Burt Nabors, Manmeet S. Ahluwalia, Roger Stupp, Minesh P. Mehta, David A. Reardon, Stuart A. Grossman, Erik P. Sulman, John H. Sampson, Simon Khagi, Michael Weller, Timothy F. Cloughesy, Patrick Y. Wen, Mustafa Khasraw
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 594–602.
https://doi.org/10.1158/1078-0432.CCR-21-2750
Published: 15 February 2022
View article titled, Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Open the PDF for Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement in another window
Journal Articles

Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials

Julia Furtner, Michael Weller, Michael Weber, Thierry Gorlia, Burt Nabors, David A. Reardon, Joerg C. Tonn, Roger Stupp, Matthias Preusser
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (1): 129–136.
https://doi.org/10.1158/1078-0432.CCR-21-1987
Published: 05 January 2022
View article titled, Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials
Open the PDF for Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials in another window
Includes: Supplementary data
Journal Articles

Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis

Farshad Nassiri, Shervin Taslimi, Justin Z. Wang, Jetan H. Badhiwala, Tatyana Dalcourt, Nazanin Ijad, Neda Pirouzmand, Saleh Almenawer, Roger Stupp, Gelareh Zadeh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2664–2672.
https://doi.org/10.1158/1078-0432.CCR-19-3359
Published: 01 June 2020
View article titled, Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis
Open the PDF for Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis in another window
Includes: Supplementary data
Journal Articles

Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations

Daniel Y. Zhang, Crismita Dmello, Li Chen, Victor A. Arrieta, Edgar Gonzalez-Buendia, J. Robert Kane, Lisa P. Magnusson, Aneta Baran, C. David James, Craig Horbinski, Alexandre Carpentier, Carole Desseaux, Michael Canney, Miguel Muzzio, Roger Stupp, Adam M. Sonabend
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (2): 477–486.
https://doi.org/10.1158/1078-0432.CCR-19-2182
Published: 15 January 2020
View article titled, Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations
Open the PDF for Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations in another window
Includes: Supplementary data
Journal Articles

Overcoming the Blood–Brain Barrier with an Implantable Ultrasound Device

Adam M. Sonabend, Roger Stupp
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (13): 3750–3752.
https://doi.org/10.1158/1078-0432.CCR-19-0932
Published: 01 July 2019
View article titled, Overcoming the Blood–Brain Barrier with an Implantable Ultrasound Device
Open the PDF for Overcoming the Blood–Brain Barrier with an Implantable Ultrasound Device in another window
Journal Articles

MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials

Monika E. Hegi, Els Genbrugge, Thierry Gorlia, Roger Stupp, Mark R. Gilbert, Olivier L. Chinot, L. Burt Nabors, Greg Jones, Wim Van Criekinge, Josef Straub, Michael Weller
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (6): 1809–1816.
https://doi.org/10.1158/1078-0432.CCR-18-3181
Published: 15 March 2019
View article titled, <em>MGMT</em> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Open the PDF for <em>MGMT</em> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials in another window
Includes: Supplementary data
Journal Articles

Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice

Pratiksha Gulati, Julia Rühl, Abhilash Kannan, Magdalena Pircher, Petra Schuberth, Katarzyna J. Nytko, Martin Pruschy, Simon Sulser, Mark Haefner, Shawn Jensen, Alex Soltermann, Wolfgang Jungraithmayr, Maya Eisenring, Thomas Winder, Panagiotis Samaras, Annett Tabor, Rene Stenger, Roger Stupp, Walter Weder, Christoph Renner, Christian Münz, Ulf Petrausch
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (16): 3981–3993.
https://doi.org/10.1158/1078-0432.CCR-17-1788
Published: 14 August 2018
View article titled, Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
Open the PDF for Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice in another window
Includes: Supplementary data
Journal Articles

IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma

Erik Ladomersky, Lijie Zhai, Alicia Lenzen, Kristen L. Lauing, Jun Qian, Denise M. Scholtens, Galina Gritsina, Xuebing Sun, Ye Liu, Fenglong Yu, Wenfeng Gong, Yong Liu, Beibei Jiang, Tristin Tang, Ricky Patel, Leonidas C. Platanias, C. David James, Roger Stupp, Rimas V. Lukas, David C. Binder, Derek A. Wainwright
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (11): 2559–2573.
https://doi.org/10.1158/1078-0432.CCR-17-3573
Published: 31 May 2018
View article titled, IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma
Open the PDF for IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma in another window
Includes: Supplementary data
Journal Articles

CAR T-Cell Therapies in Glioblastoma: A First Look

Denis Migliorini, Pierre-Yves Dietrich, Roger Stupp, Gerald P. Linette, Avery D. Posey, Jr, Carl H. June
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (3): 535–540.
https://doi.org/10.1158/1078-0432.CCR-17-2871
Published: 31 January 2018
View article titled, CAR T-Cell Therapies in Glioblastoma: A First Look
Open the PDF for CAR T-Cell Therapies in Glioblastoma: A First Look in another window
Journal Articles

Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival

Lijie Zhai, Erik Ladomersky, Kristen L. Lauing, Meijing Wu, Matthew Genet, Galina Gritsina, Balázs Győrffy, Priscilla K. Brastianos, David C. Binder, Jeffrey A. Sosman, Francis J. Giles, Charles D. James, Craig Horbinski, Roger Stupp, Derek A. Wainwright
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (21): 6650–6660.
https://doi.org/10.1158/1078-0432.CCR-17-0120
Published: 31 October 2017
View article titled, Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival
Open the PDF for Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)

Wolfgang Wick, Thierry Gorlia, Pierre Bady, Michael Platten, Martin J. van den Bent, Martin J.B. Taphoorn, Jonathan Steuve, Alba A. Brandes, Marie-France Hamou, Antje Wick, Markus Kosch, Michael Weller, Roger Stupp, Patrick Roth, Vassilis Golfinopoulos, Jean-Sebastien Frenel, Mario Campone, Damien Ricard, Christine Marosi, Salvador Villa, Astrid Weyerbrock, Kirsten Hopkins, Krisztian Homicsko, Benoit Lhermitte, Gianfranco Pesce, Monika E. Hegi
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19): 4797–4806.
https://doi.org/10.1158/1078-0432.CCR-15-3153
Published: 02 October 2016
View article titled, Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without <em>MGMT</em> Promoter Hypermethylation (EORTC 26082)
Open the PDF for Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without <em>MGMT</em> Promoter Hypermethylation (EORTC 26082) in another window
Includes: Supplementary data
Journal Articles

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, Jörg Felsberg, Joachim P. Steinbach, Antje Wick, Oliver Schnell, Peter Hau, Ulrich Herrlinger, Michael C. Sabel, Hans-Georg Wirsching, Ralf Ketter, Oliver Bähr, Michael Platten, Jörg C. Tonn, Uwe Schlegel, Christine Marosi, Roland Goldbrunner, Roger Stupp, Krisztian Homicsko, Josef Pichler, Guido Nikkhah, Jürgen Meixensberger, Peter Vajkoczy, Spyros Kollias, Johannes Hüsing, Guido Reifenberger, Wolfgang Wick
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (9): 2057–2064.
https://doi.org/10.1158/1078-0432.CCR-14-2737
Published: 30 April 2015
View article titled, <em>MGMT</em> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Open the PDF for <em>MGMT</em> Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial in another window
Includes: Supplementary data
Journal Articles

Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres

Davide Sciuscio, Annie-Claire Diserens, Kristof van Dommelen, Danielle Martinet, Greg Jones, Robert-Charles Janzer, Claudio Pollo, Marie-France Hamou, Bernd Kaina, Roger Stupp, Marc Levivier, Monika E. Hegi
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (2): 255–266.
https://doi.org/10.1158/1078-0432.CCR-10-1931
Published: 16 January 2011
View article titled, Extent and Patterns of <em>MGMT</em> Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres
Open the PDF for Extent and Patterns of <em>MGMT</em> Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres in another window
Includes: Supplementary data
Journal Articles

Epigenetic Deregulation of DNA Repair and Its Potential for Therapy

Monika E. Hegi, Davide Sciuscio, Anastasia Murat, Marc Levivier, Roger Stupp
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5026–5031.
https://doi.org/10.1158/1078-0432.CCR-08-1169
Published: 12 August 2009
View article titled, Epigenetic Deregulation of DNA Repair and Its Potential for Therapy
Open the PDF for Epigenetic Deregulation of DNA Repair and Its Potential for Therapy in another window
Journal Articles

Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments

Alba A. Brandes, Enrico Franceschi, Alicia Tosoni, Monika E. Hegi, Roger Stupp
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (4): 957–960.
https://doi.org/10.1158/1078-0432.CCR-07-1810
Published: 15 February 2008
View article titled, Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments
Open the PDF for Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments in another window
Journal Articles

Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms

Arnab Chakravarti, Michael G. Erkkinen, Ulf Nestler, Roger Stupp, Minesh Mehta, Ken Aldape, Mark R. Gilbert, Peter McL. Black, Jay S. Loeffler
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (15): 4738–4746.
https://doi.org/10.1158/1078-0432.CCR-06-0596
Published: 09 August 2006
View article titled, Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms
Open the PDF for Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms in another window
Journal Articles

Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients

Sandrine Ostermann, Chantal Csajka, Thierry Buclin, Serge Leyvraz, Ferdy Lejeune, Laurent A. Decosterd, Roger Stupp
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (11): 3728–3736.
https://doi.org/10.1158/1078-0432.CCR-03-0807
Published: 01 June 2004
View article titled, Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients
Open the PDF for Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients in another window